This is a summary of the European public assessment report (EPAR) for Dasselta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Dasselta.
Therapeutic Indication
### Therapeutic indication Dasselta is indicated for the relief of symptoms associated with: - allergic rhinitis; - urticaria.
Therapeutic Area (MeSH)
N/AATC Code
R06AX27
ATC Item
desloratadine
Pharmacotherapeutic Group
Antihistamines for systemic use
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| desloratadine | N/A | 地氯雷他定 |
EMA Name
Dasselta
Medicine Name
Dasselta
Aliases
N/ANo risk management plan link.
